Evidence map›Paper›PMID 38152611›Full record

ReviewTherapeutic advances in infectious disease

Respiratory morbidity in

Joseph Baruch Baluku, Ronald Olum, Richard E Sanya, Ponsiano Ocama

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Joseph Baruch BalukuImmunomodulation and Vaccines Programme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.ORCID https://orcid.org/0000-0002-5852-9674
Ronald OlumSt. Francis Hospital, Nsambya, Kampala, Uganda.ORCID https://orcid.org/0000-0003-1289-0111
Richard E SanyaImmunomodulation and Vaccines Programme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Ponsiano OcamaImmunomodulation and Vaccines Programme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Makerere University · UGAfrican Field Epidemiology Network · UGNsambya Hospital · UG

Funding

Uganda Schistosomiasis Multidisciplinary Research Centre (U-SMRC)U01AI168609 · NIAID · UGANDA VIRUS RESEARCH INSTITUTE · PI Alison Elliott · 2022 to 2026
$2.7M
NIAID NIH HHS U01 AI168609
6 · The paper itself

Abstract

Background: Schistosomiasis contributes to 2.5 million disability-adjusted life years globally. Acute and chronic respiratory morbidity of Methods: We carried out a comprehensive literature search in Embase and MEDLINE from the inception of the databases to 13th March 2023. Results: A total of 2243 patients with Conclusion: There is a high prevalence of respiratory morbidity among patients with

Indexed as

coughdyspneaeosinophilslung functionrespiratory symptomsSchistosoma mansoni

Identifiers

PMID38152611
PMCPMC10752101
OpenAlexW4390240170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.